32929476 31209622 33645515 35287535 30922695 31134536 28727542 30827829 30827828 33346898 31973681 33446181 32315207 31895759 32524368 32811342 34382578 35488761 34130446 33008929 35088381 28381452 30912336 30283735 32253999 34194397 33390986 3270115 - Search Results

Year	Number of Results
2017	4
2018	5
2019	13
2020	16
2021	14
2022	3

1

Management of Graves Thyroidal and Extrathyroidal Disease: An Update.

Kahaly GJ. Kahaly GJ. J Clin Endocrinol Metab. 2020 Dec 1;105(12):3704-20. doi: 10.1210/clinem/dgaa646. J Clin Endocrinol Metab. 2020. PMID: 32929476 Free PMC article. Review.

2

Two-year outcomes of single-session high-intensity focused ultrasound (HIFU) treatment in persistent or relapsed Graves' disease.

Lang BH, Woo YC, Chiu KW. Lang BH, et al. Eur Radiol. 2019 Dec;29(12):6690-6698. doi: 10.1007/s00330-019-06303-8. Epub 2019 Jun 17. Eur Radiol. 2019. PMID: 31209622

3

Methimazole Drug Allergy: A Possible Solution Using a "Methimazole Solution".

Cooper DS, Adkinson NF. Cooper DS, et al. Endocr Pract. 2021 Mar;27(3):269-270. doi: 10.1016/j.eprac.2020.12.007. Epub 2020 Dec 19. Endocr Pract. 2021. PMID: 33645515 No abstract available.

4

Management of Graves' hyperthyroidism: present and future.

Bartalena L, Piantanida E, Gallo D, Ippolito S, Tanda ML. Bartalena L, et al. Expert Rev Endocrinol Metab. 2022 Mar;17(2):153-166. doi: 10.1080/17446651.2022.2052044. Epub 2022 Mar 14. Expert Rev Endocrinol Metab. 2022. PMID: 35287535

5

Thyrotoxicosis: Diagnosis and Management.

Sharma A, Stan MN. Sharma A, et al. Mayo Clin Proc. 2019 Jun;94(6):1048-1064. doi: 10.1016/j.mayocp.2018.10.011. Epub 2019 Mar 25. Mayo Clin Proc. 2019. PMID: 30922695 Review.

6

Safety of long-term antithyroid drug treatment? A systematic review.

Azizi F, Malboosbaf R. Azizi F, et al. J Endocrinol Invest. 2019 Nov;42(11):1273-1283. doi: 10.1007/s40618-019-01054-1. Epub 2019 May 27. J Endocrinol Invest. 2019. PMID: 31134536

7

Single-Session High-Intensity Focused Ultrasound Treatment for Persistent or Relapsed Graves Disease: Preliminary Experience in a Prospective Study.

Lang BH, Woo YC, Wong IY, Chiu KW. Lang BH, et al. Radiology. 2017 Dec;285(3):1011-1022. doi: 10.1148/radiol.2017162776. Epub 2017 Jul 20. Radiology. 2017. PMID: 28727542 Clinical Trial.

8

Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.

Okosieme OE, Taylor PN, Evans C, Thayer D, Chai A, Khan I, Draman MS, Tennant B, Geen J, Sayers A, French R, Lazarus JH, Premawardhana LD, Dayan CM. Okosieme OE, et al. Lancet Diabetes Endocrinol. 2019 Apr;7(4):278-287. doi: 10.1016/S2213-8587(19)30059-2. Epub 2019 Feb 28. Lancet Diabetes Endocrinol. 2019. PMID: 30827829

9

Can a patient-tailored treatment approach for Graves' disease reduce mortality?

Bartalena L, Piantanida E, Tanda ML. Bartalena L, et al. Lancet Diabetes Endocrinol. 2019 Apr;7(4):245-246. doi: 10.1016/S2213-8587(19)30057-9. Epub 2019 Feb 28. Lancet Diabetes Endocrinol. 2019. PMID: 30827828 No abstract available.

10

Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression.

Ippolito S, Cusini C, Lasalvia P, Gianfagna F, Veronesi G, Gallo D, Masiello E, Premoli P, Sabatino J, Mercuriali A, Lai A, Piantanida E, Tanda ML, Bartalena L. Ippolito S, et al. J Endocrinol Invest. 2021 Aug;44(8):1707-1718. doi: 10.1007/s40618-020-01479-z. Epub 2020 Dec 21. J Endocrinol Invest. 2021. PMID: 33346898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results